Skip to main content

Celyad SA (CYAD.BR) Stock Price and Company Information, 2024

Celyad SA

CYAD.BR

Exchange: BR
Currency Euro
ISIN: BE0974260896
LEI: 549300ORR0M8XF56OI64
Primary Ticker: CYAD.BR
Fiscal Year End: December
International Domestic: International/Domestic
Sector: Healthcare
Industry: Biotechnology
Gic Sector: Health Care
Gic Group: Pharmaceuticals, Biotechnology & Life Sciences
Gic Industry: Biotechnology
Gic Sub Industry: Biotechnology
Description: Celyad Oncology SA, a biopharmaceutical company, focuses on the research and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. The company is developing sh RNA non-gene-edited technology, which allows for the development of allogenic CAR T-cells through the modulation of genes encoding the TCR without the need for gene editing; multi-specific CAR T-cell platform that focuses on the NKG2D receptor; NKG2D-based CAR T-cell therapies; and B7-H6 targeting CAT T-cell therapies. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery/Perkin Elmer for the use of its sh RNA reagents to reduce expression of one or more defined targets. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.
Address: Axis Business Park, Mont-Saint-Guibert, Belgium, 1435
Website: https://www.celyad.com
Full Time Employees: 17
Updated On: 2024-11-04

Highlights

Market Capitalization: 14500010
Market Capitalization Mln: 14.5
EBITDA: -7441000
Wall Street Target Price: 0.5
Book Value: 0.07
Earnings Share: -1.36
Most Recent Quarter: 2024-06-30
Operating Margin TTM: -220.28
Return On Assets TTM: -0.38
Return On Equity TTM: -3.61
Revenue TTM: 72000
Quarterly Revenue Growth YOY: -0.68
Gross Profit TTM: 5000
Diluted Eps TTM: -1.36

Valuation

Price Sales TTM: 169.74
Price Book MRQ: 11.99
Enterprise Value: 9260000
Enterprise Value Revenue: 176.85
Enterprise Value Ebitda: -0.3

Technicals

Beta: 1.51
52 Week High: 0.62
52 Week Low: 0.21
50 Day MA: 0.25
200 Day MA: 0.30

Earnings

Report Date: 2025-04-02
Date: 2025-03-31
Before After Market: After Market
Report Date: 2024-11-07
Date: 2024-09-30
Before After Market: Before Market
Report Date: 2023-11-09
Date: 2023-09-30
Before After Market: Before Market
Report Date: 2023-09-04
Date: 2023-06-30
Before After Market: After Market
Eps Estimate: -0.44
Eps Difference: 0.44
Surprise Percent: 10
Report Date: 2023-05-05
Date: 2023-03-31
Before After Market: Before Market
Report Date: 2023-03-23
Date: 2022-12-31
Before After Market: After Market
Eps Actual: -1.19
Eps Estimate: -0.62
Eps Difference: -0.56
Surprise Percent: -90.98
Report Date: 2022-11-10
Date: 2022-09-30
Before After Market: After Market
Report Date: 2022-08-05
Date: 2022-06-30
Before After Market: Before Market
Eps Actual: -0.86
Eps Estimate: -0.86
Report Date: 2022-05-05
Date: 2022-03-31
Report Date: 2022-03-24
Date: 2021-12-31
Eps Actual: -0.64
Eps Estimate: -0.64
Report Date: 2021-11-10
Date: 2021-09-30
Report Date: 2021-08-04
Date: 2021-06-30
Eps Actual: -1.09
Eps Estimate: -1.09
Report Date: 2021-05-06
Date: 2021-03-31
Report Date: 2021-03-24
Date: 2020-12-31
Eps Actual: -0.04
Eps Difference: -0.04
Report Date: 2020-11-10
Date: 2020-09-30
Report Date: 2020-08-06
Date: 2020-06-30
Eps Actual: -1.19
Eps Estimate: -0.32
Eps Difference: -0.87
Surprise Percent: -271.87
Report Date: 2020-05-07
Date: 2020-03-31
Report Date: 2020-03-24
Date: 2019-12-31
Eps Actual: -0.95
Eps Estimate: -1.48
Eps Difference: 0.53
Surprise Percent: 35.81
Report Date: 2019-11-19
Date: 2019-09-30
Report Date: 2019-08-22
Date: 2019-06-30
Eps Actual: -1.75
Eps Estimate: -1.75
Report Date: 2019-05-09
Date: 2019-03-31
Report Date: 2019-03-28
Date: 2018-12-31
Eps Actual: -1.68
Eps Estimate: -1.68
Report Date: 2018-11-19
Date: 2018-09-30
Report Date: 2018-08-23
Date: 2018-06-30
Eps Actual: -1.81
Eps Estimate: -1.79
Eps Difference: -0.02
Surprise Percent: -1.11
Report Date: 2018-05-30
Date: 2018-03-31
Report Date: 2018-03-22
Date: 2017-12-31
Eps Actual: -4.46
Eps Estimate: -1.51
Eps Difference: -2.95
Surprise Percent: -195.36
Report Date: 2017-11-17
Date: 2017-09-30
Eps Estimate: -2.88
Eps Difference: 2.88
Surprise Percent: 10
Report Date: 2017-08-29
Date: 2017-06-30
Eps Actual: -1.52
Eps Estimate: -2.86
Eps Difference: 1.34
Surprise Percent: 46.85
Report Date: 2017-05-19
Date: 2017-03-31
Eps Estimate: -2.14
Eps Difference: 2.14
Surprise Percent: 10
Report Date: 2017-03-23
Date: 2016-12-31
Eps Actual: -0.72
Eps Estimate: -1.98
Eps Difference: 1.26
Surprise Percent: 63.63
Report Date: 2016-11-18
Date: 2016-09-30
Eps Estimate: -1.35
Eps Difference: 1.35
Surprise Percent: 10
Report Date: 2016-08-25
Date: 2016-06-30
Eps Actual: -1.82
Eps Estimate: -1.88
Eps Difference: 0.06
Surprise Percent: 3.19
Report Date: 2016-04-27
Date: 2016-03-31
Eps Actual: -1.43
Eps Estimate: -1.77
Eps Difference: 0.34
Surprise Percent: 19.20
Report Date: 2013-12-31
Date: 2013-12-31
Eps Actual: -0.93
Date: 2024-12-31
Period: +1y
Revenue Estimate Number Of Analysts: 1.00
Date: 2024-03-31
Period: +1q
Date: 2023-12-31
Revenue Estimate Number Of Analysts: 1.00
Eps Trend7days Ago: 0.64
Eps Trend30days Ago: 0.64
Eps Trend60days Ago: 0.64
Eps Trend90days Ago: 0.64
Date: 2023-09-30
Date: 2023-06-30
Date: 2023-03-31
Date: 2022-12-31
Growth: 0.20
Earnings Estimate Year Ago Eps: -1.70
Earnings Estimate Growth: 0.20
Revenue Estimate Number Of Analysts: 1.00
Eps Trend7days Ago: -1.35
Eps Trend30days Ago: -1.35
Eps Trend60days Ago: -1.35
Eps Trend90days Ago: -1.35
Date: 2022-09-30
Date: 2022-06-30
Date: 2022-03-31
Period: +1q
Date: 2021-12-31
Revenue Estimate Number Of Analysts: 1.00
Date: 2019-12-31
Period: +1y
Revenue Estimate Avg: 11060000.00
Revenue Estimate High: 28300000.00
Revenue Estimate Number Of Analysts: 5.00
Revenue Estimate Growth: 1.34
Eps Trend7days Ago: -2.36
Eps Trend30days Ago: -2.36
Eps Trend60days Ago: -2.36
Eps Trend90days Ago: -2.36
Date: 2019-06-30
Period: +1q
Revenue Estimate Avg: 4720000.00
Revenue Estimate High: 15000000.00
Revenue Estimate Number Of Analysts: 6.00
Revenue Estimate Growth: 0.33
Date: 2019-03-31
Revenue Estimate Avg: 4720000.00
Revenue Estimate High: 15000000.00
Revenue Estimate Number Of Analysts: 6.00
Revenue Estimate Growth: 0.33
Date: 2018-12-31
Revenue Estimate Avg: 4720000.00
Revenue Estimate High: 15000000.00
Revenue Estimate Number Of Analysts: 6.00
Revenue Estimate Growth: 0.33
Eps Trend7days Ago: -4.02
Eps Trend30days Ago: -4.02
Eps Trend60days Ago: -4.02
Eps Trend90days Ago: -4.02
Date: 2024-09-30
Date: 2022-12-31
Eps Actual: -2.05
Date: 2021-12-31
Eps Actual: -1.73
Date: 2020-12-31
Eps Actual: -1.2
Date: 2019-12-31
Eps Actual: -2.
Date: 2018-12-31
Eps Actual: -3.4
Date: 2017-12-31
Eps Actual: -5.9
Date: 2016-12-31
Eps Actual: -3.9
Date: 2013-12-31
Eps Actual: -0.93